Decision to Provide Collateral for Refinancing of Magok R&D Center PF Loan


  • Decision to provide collateral to a special purpose company (Magok Consortium First Co., Ltd.) for the purpose of refinancing existing PF loans related to the Magok R&D center development project
  • Collateral amount of 54.6 billion KRW (22.13% of equity of 246.8 billion KRW)
  • Based on the company's liability share of 28% and the creditor's required collateral ratio of 120%, the secured debt amount is 45.5 billion KRW
  • Collateral period: 2026-05-12 to 2027-11-11 (18 months)
  • The company is in the process of selling the Magok R&D center to improve asset management efficiency and secure liquidity

KOSDAQ Filing Information


  • Filing: Decision on Provision of Collateral for Others
  • Company: Genexine (095700)
  • Submission: Genexine, Inc.
  • Receipt: 05-06-2026
  • Under KRX KOSDAQ Market Division